title: [Transfection of hBcl-2 gene protects the liver against ischemia/reperfusion injury in rats during liver transplantation].
abstract: OBJECTIVE
  To study the effect of hBcl-2 gene transfer on rat liver against ischemia-reperfusion injury, and explore the feasibility of this approach to reduce ischemia-reperfusion injury in liver transplantation.
  
  
  METHODS
  We constructed the replication-deficient recombinant adenoviruses Adv-EGFP and Adv-Bcl-2 and transfected them into 293 cells and packaged into adenovirus particles for amplification and purification. The empty plasmid vector virus was constructed similarly. Male SD rats were randomized into Adv-Bcl-2-transfected group, Adv-EGFP-transfected group, ischemia-reperfusion group, and sham-operated group, and liver allograft transplantation model was established by sleeve method. In the transfected groups, the recombinant viruses were administered by perfusion through the portal vein, and the ischemia-reperfusion and sham-operated groups received no treatment. Real-time quantitative PCR and Western blotting were used to detect the mRNA and protein expressions of bcl-2 in the liver tissue of each group, and at 0, 60 and 180 min after reperfusion, serum AST, LDH, and MDA levels were measured. Histological changes of the liver cells were evaluated by HE staining.
  
  
  RESULTS
  Bcl-2 mRNA and protein expressions in Adv-Bcl-2-transfected group, as compared with those in Adv-EGFP-transfected group and control group, were significantly increased (P<0.01); the serum levels of AST, LDH and MDA in Adv-Bcl-2-transfected group were significantly lower than those of Adv-EGFP-transfected group and ischemia-reperfusion group (P<0.05 or 0.01). Compared with the sham-operated group, Adv-Bcl-2 treatment group showed lessened edema and vacuolar degeneration of the liver cells without patches or spots of necrosis. In ischemia-reperfusion and Adv-EGFP group, HE staining revealed hepatic lobular destruction and extensive liver cell swelling, enlargement, vacuolar degeneration, edema and occasional focal necrosis.
  
  
  CONCLUSIONS
  Adv-Bcl-2 transfection can induce the expression of bcl-2 gene to reduce ischemia-reperfusion injury of the liver graft in rats.
authors.affiliation: Department of Anesthesiology, People's Hospital of Hunan Province, Changsha, China. tigerliu007@sina.com
authors.forename: Ji-tong
authors.initials: JT
authors.lastname: Liu
authors.forename: Jing-shi
authors.initials: JS
authors.lastname: Liu
authors.forename: Jin-yu
authors.initials: JY
authors.lastname: Jiang
authors.forename: Li-xue
authors.initials: LX
authors.lastname: Zhou
authors.forename: Gang
authors.initials: G
authors.lastname: Liang
authors.forename: Yan-chun
authors.initials: YC
authors.lastname: Li
mesh_terms: D000818:Animals; D019254:Genes, bcl-2; D008099:Liver / Q000098:blood supply; D016031:Liver Transplantation; D008297:Male; D051381:Rats; D017207:Rats, Sprague-Dawley; D015427:Reperfusion Injury / Q000473:pathology / Q000517:prevention & control*; D014162:Transfection